ACL offers sell-off to win approval for $1.5B Healius merger
Blood vials, pathology
Corporate 2023-10-03 1:17 pm By Sam Matthews | Melbourne
Please login to bookmark Close

Pathology giant Australian Clinical Labs has proposed a divestiture of collection centres amid competition concerns about its proposed takeover of competitor Healius, the owner of Dorevitch Pathology.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au